AKT1 and cholangiocarcinoma: To further demonstrate that Tan-IIA affects the growth of Cholangiocarcinoma cells by suppressing the PI3K/Akt/mTOR signaling pathway, Cholangiocarcinoma cells were pretreated with 740 y-p (PI3K agonist) or without it in the presence of Tan-IIA.